Schedule 13G ownership disclosure

Arno Therapeutics, Inc

Security class unavailable · CUSIP: 042564203

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
20,429,001
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-15-000083
Form type
SC 13G/A
Filer
Arno Therapeutics, Inc
CIK
CIK 1195116
Filed
Feb 13, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub